Ameriprise
DOVA

Ameriprise’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Ameriprise’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,679
Closed -$622K – 3823
2018
Q3 		$622K Sell
29,679
-31,880
-52% -$759K ﹤0.01% 3229
2018
Q2 		$1.84M Buy
61,559
+5,590
+10% +$152K ﹤0.01% 2766
2018
Q1 		$1.52M Buy
55,969
+4,200
+8% +$126K ﹤0.01% 2800
2017
Q4 		$1.49M Buy
51,769
+2,500
+5% +$68.5K ﹤0.01% 2807
2017
Q3 		$1.2M Buy
49,269
+19,300
+64% +$458K ﹤0.01% 2881
2017
Q2 		$668K Buy
+29,969
New +$631K ﹤0.01% 3120

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's DOVA Position: Q4 2018 in Review

Ameriprise sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2018, closing a stake of 29,679 shares — an estimated $622K sold.

Ameriprise first reported a position in DOVA in Q2 2017 and held it in 6 quarters. The position peaked at $1.84M in Q2 2018. 58 funds tracked by Wall St. Rank hold DOVA as of Q4 2018.

  • Ameriprise reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Ameriprise sold 29,679 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2018, an estimated $622K.
  • Ameriprise first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
  • Ameriprise's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.84M in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2018.

Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.